In AMD patients, downregulation of methylation of the interleukin 17 receptor C (IL17RC) promoter that regulates the expression of the IL-17 receptor and modulates the inflammatory responses of IL-17A and IL-17F was reported [73]. This evidence concerns the gene IL17RC and age-related macular degeneration.